The mechanisms of angiogenesis in hepatocellular carcinoma: Angiogenic switch during tumor progression

Surgery - Tập 131 - Trang S135-S141 - 2002
Keishi Sugimachi1, Shinji Tanaka1, Takahiro Terashi1, Ken-ichi Taguchi1, Tatsuya Rikimaru1, Keizo Sugimachi1
1Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Tài liệu tham khảo

Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7 Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, 27, 10.1038/nm0195-27 Gale, 1999, Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development, Genes Dev, 13, 1055, 10.1101/gad.13.9.1055 Ferrara, 1999, Clinical applications of angiogenic growth factors and their inhibitors, Nat Med, 5, 1359, 10.1038/70928 Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994 Honda, 2000, Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules, J Hepatobiliary Pancreat Surg, 7, 245, 10.1007/s005340070044 Maeda, 1995, CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumour progression and angiographic findings, J Gastroenterol Hepatol, 10, 650, 10.1111/j.1440-1746.1995.tb01365.x Sonoda, 1989, Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment, Hepatology, 10, 1003, 10.1002/hep.1840100619 Sakamoto, 1993, Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma, Jpn J Clin Oncol, 23, 98 Folkman, 1998, Antiangiogenic gene therapy, Proc Natl Acad Sci U S A, 95, 9064, 10.1073/pnas.95.16.9064 Ferrara, 1997, The biology of vascular endothelial growth factor, Endocr Rev, 18, 4, 10.1210/er.18.1.4 Kukk, 1996, VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development, Development, 122, 3829, 10.1242/dev.122.12.3829 Leung, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, 246, 1306, 10.1126/science.2479986 Shweiki, 1992, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, 359, 843, 10.1038/359843a0 Gleadle, 1998, Hypoxia and the regulation of gene expression, Mol Med Today, 4, 122, 10.1016/S1357-4310(97)01198-2 Pertovaara, 1994, Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells, J Biol Chem, 269, 6271, 10.1016/S0021-9258(17)37365-9 Kieser, 1994, Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression, Oncogene, 9, 963 Rak, 1995, Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis, Cancer Res, 55, 4575 Mise, 1996, Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor, Hepatology, 23, 455, 10.1002/hep.510230309 Suzuki, 1996, Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma, Cancer Res, 56, 3004 Kawahara, 1998, Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma, Hepatology, 28, 1512, 10.1002/hep.510280610 El-Assal, 1998, Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver, Hepatology, 27, 1554, 10.1002/hep.510270613 Shimoda, 1999, Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma, Int J Oncol, 14, 353 Okuda, 2000, Hepatocellular carcinoma, J Hepatol, 32, 225, 10.1016/S0168-8278(00)80428-6 Yamaguchi, 1998, Expression of vascular endothelial growth factor in human hepatocellular carcinoma, Hepatology, 28, 68, 10.1002/hep.510280111 Davis, 1996, Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning, Cell, 87, 1161, 10.1016/S0092-8674(00)81812-7 Sato, 1993, Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system, Proc Natl Acad Sci U S A, 90, 9355, 10.1073/pnas.90.20.9355 Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55 Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9 Fachinger, 1999, Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2, Oncogene, 18, 5948, 10.1038/sj.onc.1202992 Stratmann, 1998, Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis, Am J Pathol, 153, 1459, 10.1016/S0002-9440(10)65733-1 Brown, 2000, Expression of tie1, tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma, Am J Pathol, 156, 2179, 10.1016/S0002-9440(10)65088-2 Peters, 1998, Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis, Br J Cancer, 77, 51, 10.1038/bjc.1998.8 Tanaka, 1999, Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma, J Clin Invest, 103, 341, 10.1172/JCI4891 Yamashita, 2001, Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model, Cancer Res, 61, 1005 Kim, 1998, Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma, Cancer Res, 58, 348 Lin, 1998, Anti-angiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2, Proc Natl Acad Sci U S A, 95, 8829, 10.1073/pnas.95.15.8829 Kin, 2000, Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats, Int J Oncol, 16, 375